METHOD OF TREATING IMMUNOLOGICAL DISORDERS MEDIATED BY T-LYMPHOCYTES
摘要
<p>The use of soluble epoxide hydrolase inhibitors in the treatment of T-lymphocyte mediated immunological disorders is described either as monotherapies or as part of combination therapies for such disorers.</p>
